{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:56:50Z","timestamp":1789466210207,"version":"build-2803163510"},"reference-count":134,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Heart failure (HF) is a multifaceted clinical syndrome marked by the heart\u2019s inability to pump sufficient blood, resulting in symptoms such as dyspnea, fatigue, and fluid retention. Among the emerging therapeutic strategies for managing HF, targeting the transcription factor forkhead box O3 (FOXO3) has garnered attention due to its regulatory role in cellular processes related to oxidative stress, apoptosis, autophagy, and inflammation. Dysregulation of FOXO3 has been implicated in the progression of HF, making it a notable focus for potential therapeutic interventions aimed at improving cardiac function and patient outcomes. Research into FOXO3-targeting compounds has identified various classes of agents, including phytochemicals and pharmaceuticals. These compounds work through mechanisms such as interaction with upstream signaling pathways and downstream target genes of FOXO3. While preclinical studies show promise for FOXO3 targeting compounds in promoting cardiac health and function, challenges remain in translating these findings into successful clinical applications. In this review article, we focus on the FOXO3 modulators investigated between 2006 and 2026 that have shown beneficial effects on heart function in diverse experimental models. Furthermore, we discuss current methodological limitations in this research field and propose potential directions for future studies on heart health management.<\/jats:p>","DOI":"10.3390\/ph19091460","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:16:48Z","timestamp":1789460208000},"page":"1460","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting FOXO3 for the Management of Heart Failure: Current Evidence and Future Directions"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-7389","authenticated-orcid":false,"given":"See-Hyoung","family":"Park","sequence":"first","affiliation":[{"name":"Department of Biological and Chemical Engineering, Hongik University, Sejong 30016, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref_1","first-page":"148","article-title":"AHA\/ACC\/ESC\/WHF expert consensus document: Second universal definition of heart failure (2026)","volume":"56","author":"Walsh","year":"2026","journal-title":"JACC"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Paraskevaidis, I., Tsougos, E., and Kourek, C. (2025). One syndrome, many faces: A unified perspective on heart failure phenotypes. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26188960"},{"key":"ref_3","unstructured":"K\u00f8ber, L., Adamo, M., Ruwald, A.-C., Tomasoni, D., Anderson, L.J., Andersson, C., Brugts, J.J., Chioncel, O., Donal, E., and Ferdinandy, P. (2026). 2026 ESC Guidelines for the management of heart failure: Developed by the task force for the management of heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J., ehag100."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.36628\/ijhf.2024.0010","article-title":"Heart failure statistics 2024 update: A report from the Korean Society of Heart Failure","volume":"6","author":"Lee","year":"2024","journal-title":"Int. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.36628\/ijhf.2026.0001","article-title":"Heart failure statistics 2025 update: A report from the Korean Society of Heart Failure","volume":"8","author":"Lee","year":"2026","journal-title":"Int. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/heartjnl-2022-321702","article-title":"Prevalence, outcomes and costs of a contemporary, multinational population with heart failure","volume":"109","author":"Norhammar","year":"2023","journal-title":"Heart"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Becher, P.M., Lund, L.H., Coats, A.J., and Savarese, G. (2022). An Update on Global Epidemiology in Heart Failure, Oxford University Press.","DOI":"10.1093\/eurheartj\/ehac248"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chen, C., Zhong, W., Zheng, H., Zhao, W., Wang, Y., and Shen, B. (2025). Current state of heart failure treatment: Are mesenchymal stem cells and their exosomes a future therapy?. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1518036"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Sympathetic nervous system activation in human heart failure: Clinical implications of an updated model","volume":"54","author":"Floras","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1172\/JCI87491","article-title":"The extracellular matrix in myocardial injury, repair, and remodeling","volume":"127","author":"Frangogiannis","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.15420\/cfr.2025.02","article-title":"Addressing endothelial dysfunction in heart failure: The role of endothelial progenitor cells and new treatment horizons","volume":"11","author":"Carulli","year":"2025","journal-title":"Card. Fail. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Manolis, A.A., Manolis, T.A., and Manolis, A.S. (2023). Neurohumoral activation in heart failure. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015472"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3892\/etm.2022.11357","article-title":"Myocardial ischemia\/reperfusion injury: Mechanisms of injury and implications for management","volume":"23","author":"He","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/cvr\/cvaa012","article-title":"Genetic lineage tracing reveals poor angiogenic potential of cardiac endothelial cells","volume":"117","author":"Kocijan","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Yang, H.-M. (2025). Mitochondrial dysfunction in cardiovascular diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051917"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.36628\/ijhf.2023.0058","article-title":"Precision cardiology: Phenotype-targeted therapies for HFmrEF and HFpEF","volume":"6","author":"Rosano","year":"2024","journal-title":"Int. J. Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/ejhf.3260","article-title":"OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry","volume":"26","author":"Inciardi","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Topf, A., Mirna, M., Ohnewein, B., Jirak, P., Kopp, K., Fejzic, D., Haslinger, M., Motloch, L.J., Hoppe, U.C., and Berezin, A. (2020). The diagnostic and therapeutic value of multimarker analysis in heart failure. An approach to biomarker-targeted therapy. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.579567"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Stoicescu, L., Cri\u015fan, D., Morgovan, C., Avram, L., and Ghibu, S. (2024). Heart failure with preserved ejection fraction: The pathophysiological mechanisms behind the clinical phenotypes and the therapeutic approach. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020794"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40959-026-00518-7","article-title":"Diagnostic and prognostic biomarkers in heart failure and myeloproliferative neoplasms: Clinical applications and risk scores\u2013a narrative review","volume":"12","author":"Muraretu","year":"2026","journal-title":"Cardio-Oncology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbadis.2016.11.023","article-title":"FOXOs in the impaired heart: New therapeutic targets for cardiac diseases","volume":"1863","author":"Xin","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) -Mol. Basis Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Park, S.-H. (2024). Role of phytochemicals in treatment of aging and cancer: Focus on mechanism of FOXO3 activation. Antioxidants, 13.","DOI":"10.3390\/antiox13091099"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Park, S.-H. (2025). Recent Research on the Role of Phytochemicals from Ginseng in Management of Osteosarcoma, Osteoporosis, and Osteoarthritis. Nutrients, 17.","DOI":"10.3390\/nu17111910"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-physiol-021909-135931","article-title":"The FoxO family in cardiac function and dysfunction","volume":"72","author":"Ronnebaum","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/heartjnl-2022-321732","article-title":"FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy","volume":"109","author":"Escher","year":"2023","journal-title":"Heart"},{"key":"ref_32","first-page":"101540","article-title":"LVAD Therapy Improves Metabolic and Inflammatory State in the Heart","volume":"11","author":"Mury","year":"2026","journal-title":"Basic Transl. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-372","DOI":"10.12688\/f1000research.15258.1","article-title":"Recent advances in understanding the role of FOXO3","volume":"7","author":"Stefanetti","year":"2018","journal-title":"F1000Research"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12265-010-9200-z","article-title":"FoxO, autophagy, and cardiac remodeling","volume":"3","author":"Ferdous","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e70775","DOI":"10.1111\/jcmm.70775","article-title":"FoxO3 Activation Alleviates Doxorubicin-Induced Cardiomyopathy by Enhancing Autophagic Flux and Suppressing mTOR\/ROS Signalling","volume":"29","author":"Chang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1074\/jbc.M110.179242","article-title":"FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress","volume":"286","author":"Sengupta","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.21037\/atm-21-5602","article-title":"Homocysteine promotes cardiac fibrosis by regulating the Akt\/FoxO3 pathway","volume":"9","author":"Shi","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/s41467-025-57962-9","article-title":"FoxO3 controls cardiomyocyte proliferation and heart regeneration by regulating Sfrp2 expression in postnatal mice","volume":"16","author":"Xia","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"110141","DOI":"10.1016\/j.cellsig.2021.110141","article-title":"Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia\/reperfusion injury by transcriptional activation of CXCL16","volume":"87","author":"Zhao","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/cvr\/cvr144","article-title":"FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model","volume":"91","author":"Schips","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.yjmcc.2008.09.651","article-title":"Resveratrol activates protein deacetylase SIRT1 and prolongs the survival of heart failure animals by up-regulating MnSOD through transactivation of FOXO3a","volume":"45","author":"Kuno","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.niox.2013.04.001","article-title":"Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol","volume":"32","author":"Xia","year":"2013","journal-title":"Nitric Oxide"},{"key":"ref_43","first-page":"A13769","article-title":"Role of FOXO Transcription Factors in the Protective Mechanism by Resveratrol Against Cardiomyopathy in the Dystrophin-deficient Mdx Mouse","volume":"130","author":"Kuno","year":"2014","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"116476","DOI":"10.1016\/j.biopha.2024.116476","article-title":"Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3\/FOXO3a signaling pathway and restoring redox homeostasis","volume":"174","author":"Zhu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e002648","DOI":"10.1161\/JAHA.115.002648","article-title":"Resveratrol ameliorates cardiac hypertrophy by down-regulation of miR-155 through activation of breast cancer type 1 susceptibility protein","volume":"5","author":"Fan","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zheng, M., Bai, Y., Sun, X., Fu, R., Liu, L., Liu, M., Li, Z., and Huang, X. (2022). Resveratrol reestablishes mitochondrial quality control in myocardial ischemia\/reperfusion injury through Sirt1\/Sirt3-Mfn2-Parkin-PGC-1\u03b1 pathway. Molecules, 27.","DOI":"10.3390\/molecules27175545"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1139\/Y10-082","article-title":"Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action","volume":"88","author":"Mukherjee","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.31083\/ph.2016.6597","article-title":"Resveratrol protects against triptolide-induced cardiotoxicity through SIRT3 signaling pathway in vivo and in vitro","volume":"71","author":"Yang","year":"2016","journal-title":"Pharmazie"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15555","DOI":"10.1038\/s41598-018-33930-w","article-title":"Resveratrol ameliorates mitophagy disturbance and improves cardiac pathophysiology of dystrophin-deficient mdx mice","volume":"8","author":"Kuno","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104952","DOI":"10.1016\/j.ebiom.2023.104952","article-title":"Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid","volume":"100","author":"Lau","year":"2024","journal-title":"EBioMedicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.1007\/s11357-014-9705-5","article-title":"Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K\/Akt signaling to improve the effects of exercise in elderly rat hearts","volume":"36","author":"Lin","year":"2014","journal-title":"Age"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FJC.0000000000000504","article-title":"Resveratrol ameliorates cardiac dysfunction by inhibiting apoptosis via the PI3K\/Akt\/FoxO3a pathway in a rat model of diabetic cardiomyopathy","volume":"70","author":"Wu","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_53","first-page":"e11186","article-title":"Mediation of FOXO3 Gene on the Momism of Quercetin Against Isoproterenol Induced Cardiotoxicity on H9c2 Cardiomyoblasts","volume":"11","author":"Ramachandran","year":"2017","journal-title":"Int. Cardiovasc. Res. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/15384101.2021.1932029","article-title":"Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p\/FOXO3","volume":"20","author":"Hu","year":"2021","journal-title":"Cell Cycle"},{"key":"ref_55","first-page":"559","article-title":"The role of quercetin and exercise in modulating apoptosis and cardiomyopathy via PI3K\/AKT\/FOXO3 pathways in diabetic obese rats","volume":"26","author":"Khajehlandi","year":"2024","journal-title":"Cell J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1111\/jcmm.13924","article-title":"Cardioprotective effects of the novel curcumin analogue C66 in diabetic mice is dependent on JNK 2 inactivation","volume":"22","author":"Li","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"155127","DOI":"10.1016\/j.phymed.2023.155127","article-title":"Tetrahydrocurcumin ameliorates postinfarction cardiac dysfunction and remodeling by inhibiting oxidative stress and preserving mitochondrial function via SIRT3 signaling pathway","volume":"121","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ijmm.2025.5492","article-title":"Curcumin attenuates myocardial ischemia-reperfusion-induced autophagy-dependent ferroptosis via Sirt1\/AKT\/FoxO3a signaling","volume":"55","author":"Zhao","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ma, L., Liu, H., Xie, Z., Yang, S., Xu, W., Hou, J., and Yu, B. (2014). Ginsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-\u03baB pathway: A mouse cardiomyocyte model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103628"},{"key":"ref_60","first-page":"389","article-title":"Ginsenoside Rg1 induces ferroptosis by regulating the focal adhesion kinase\/protein kinase B-forkhead box O3A signaling pathway and alleviates sepsis-induced myocardial damage","volume":"75","author":"Lin","year":"2024","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10735-025-10417-3","article-title":"STAT3\/FoxO3a\/Sirt1 pathway inhibition by ginsenoside Rc ameliorates cardiomyocyte damage in septic cardiomyopathy by altering macrophage polarization","volume":"56","author":"Wang","year":"2025","journal-title":"J. Mol. Histol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/bph.70022","article-title":"Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator","volume":"182","author":"Gong","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"117716","DOI":"10.1016\/j.biopha.2024.117716","article-title":"Resveratrol alleviates heart failure by activating foxo3a to counteract oxidative stress and apoptosis","volume":"181","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/jcmm.15904","article-title":"Echinacoside reverses myocardial remodeling and improves heart function via regulating SIRT1\/FOXO3a\/MnSOD axis in HF rats induced by isoproterenol","volume":"25","author":"Ni","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/jcmm.16329","article-title":"Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.37290\/ctnr2641-452X.20:447-453","article-title":"Bergenin Alleviates Oxidative Stress and Apoptosis of Cardiomyocytes Induced by Oxygen-Glucose Deprivation Via Activating SIRT1\/FOXO3a\/MnSOD Pathway","volume":"20","author":"Zhang","year":"2022","journal-title":"Curr. Top. Nutraceutical Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1248\/bpb.b24-00122","article-title":"5-Demethylnobiletin ameliorates isoproterenol-induced cardiac fibrosis and apoptosis by repressing the Sirt1\/FOXO3a\/NF-\u03baB and Wnt\/\u03b2-catenin pathways","volume":"47","author":"Du","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1038\/s41598-023-31231-5","article-title":"Acetovanillone augmented the cardioprotective effect of carvedilol against cadmium-induced heart injury via suppression of oxidative stress and inflammation signaling pathways","volume":"13","author":"Hassanein","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1039\/D2FO00772J","article-title":"Daidzein alleviates doxorubicin-induced heart failure via the SIRT3\/FOXO3a signaling pathway","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1021\/jf802050h","article-title":"Akt\/FOXO3a\/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: Switching gears toward survival and longevity","volume":"56","author":"Samuel","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jjcc.2013.06.008","article-title":"Puerarin attenuates pressure overload-induced cardiac hypertrophy","volume":"63","author":"Yuan","year":"2014","journal-title":"J. Cardiol."},{"key":"ref_72","first-page":"116","article-title":"A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3","volume":"1","author":"Wang","year":"2009","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3109\/10715762.2014.920955","article-title":"(\u2013)-Epigallocatechin-3-gallate attenuated myocardial mitochondrial dysfunction and autophagy in diabetic Goto\u2013Kakizaki rats","volume":"48","author":"Liu","year":"2014","journal-title":"Free Radic. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s13577-026-01362-8","article-title":"Herbacetin alleviates acute doxorubicin cardiotoxicity via regulating the ERK1\/2-FOXO3a signaling pathway","volume":"39","author":"Bian","year":"2026","journal-title":"Hum. Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1021\/jf801473v","article-title":"White wine induced cardioprotection against ischemia-reperfusion injury is mediated by life extending Akt\/FOXO3a\/NF\u03baB survival pathway","volume":"56","author":"Thirunavukkarasu","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41598-020-80861-6","article-title":"Validation of efficacy and mechanism of Sanwei-Tanxiang powder in improving myocardial ischemia reperfusion injuries","volume":"11","author":"Sun","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11010-021-04313-z","article-title":"Blueberry extract attenuates norepinephrine-induced oxidative stress and apoptosis in H9c2 cardiac cells","volume":"477","author":"Talwar","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"118821","DOI":"10.1016\/j.jep.2024.118821","article-title":"Traditional Chinese medication qili qiangxin capsule protects against myocardial ischemia-reperfusion injury through suppressing autophagy via the phosphoinositide 3-kinase\/protein kinase B\/forkhead box O3 axis","volume":"337","author":"Wu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"113564","DOI":"10.1016\/j.biopha.2022.113564","article-title":"Gentianella acuta improves TAC-induced cardiac remodelling by regulating the Notch and PI3K\/Akt\/FOXO1\/3 pathways","volume":"154","author":"Zhou","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"156529","DOI":"10.1016\/j.phymed.2025.156529","article-title":"Linggui Zhugan decoction ameliorating mitochondrial damage of doxorubicin-induced cardiotoxicity by modulating the AMPK-FOXO3a pathway targeting BTG2","volume":"139","author":"Kong","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ptr.5961","article-title":"Panax notoginseng saponins attenuate cardiomyocyte apoptosis through mitochondrial pathway in natural aging rats","volume":"32","author":"Zhou","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7784021","DOI":"10.1155\/2022\/7784021","article-title":"Investigation of the potential key genes and the multitarget mechanisms of Polygonum cuspidatum against Heart failure based on network pharmacology and experimental validation","volume":"2022","author":"Guo","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.RES.0000254704.92532.b9","article-title":"Critical role for FoxO3a-dependent regulation of p21CIP1\/WAF1 in response to statin signaling in cardiac myocytes","volume":"100","author":"Hauck","year":"2007","journal-title":"Circ. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00204-014-1378-4","article-title":"Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo","volume":"90","author":"Bonifacio","year":"2016","journal-title":"Arch. Toxicol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cbin.10236","article-title":"Simvastatin promotes cardiac microvascular endothelial cells proliferation, migration and survival by phosphorylation of p70 S6K and FoxO3a","volume":"38","author":"Pan","year":"2014","journal-title":"Cell Biol. Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"123798","DOI":"10.1016\/j.lfs.2025.123798","article-title":"Dapagliflozin promotes metabolic reprogramming against myocardial infarction through the MAPK-FOXO3-STC1 and HIF-1a-STC1 pathways","volume":"377","author":"Zhang","year":"2025","journal-title":"Life Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"608","DOI":"10.17305\/bb.2024.11361","article-title":"Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model","volume":"25","author":"Lee","year":"2024","journal-title":"Biomol. Biomed."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.07.042","article-title":"Metoprolol increases the expression of \u03b23-adrenoceptors in the diabetic heart: Effects on nitric oxide signaling and forkhead transcription factor-3","volume":"595","author":"Sharma","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","article-title":"Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion","volume":"72","author":"Aune","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.22514\/sv.2024.116","article-title":"Artesunate inhibits ROS production and ameliorates mitochondrial damage through the SIRT1\/FOXO3a\/MnSOD pathway to alleviate heart failure","volume":"20","author":"Li","year":"2024","journal-title":"Signa Vitae"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4070\/kcj.2023.0197","article-title":"Dronedarone attenuates Ang II-induced myocardial hypertrophy through regulating SIRT1\/FOXO3\/PKIA axis","volume":"54","author":"Chen","year":"2024","journal-title":"Korean Circ. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"H1365","DOI":"10.1152\/ajpheart.01005.2007","article-title":"Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt\/FOXO pathway in rat myocardium","volume":"294","author":"Juhasz","year":"2008","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Ho, J.-H., Baskaran, R., Wang, M.-F., Yang, H.-S., Lo, Y.-H., Mohammedsaleh, Z.M., and Lin, W.-T. (2022). Bioactive peptides and exercise modulate the AMPK\/SIRT1\/PGC-1\u03b1\/FOXO3 pathway as a therapeutic approach for hypertensive rats. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070819"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Baskaran, R., Balasubramanian, B., Ho, J.-H., Wang, M.-F., Abomughaid, M.M., Yang, H.-S., and Lin, W.-T. (2022). VH-4-A bioactive peptide from soybean and exercise training constrict hypertension in rats through activating cell survival and AMPK\u03b11, Sirt1, PGC1\u03b1, and FoX3\u03b1. Molecules, 27.","DOI":"10.3390\/molecules27227705"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/jcmm.16052","article-title":"Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00726-023-03275-4","article-title":"Interaction of exercise training with taurine attenuates infarct size and cardiac dysfunction via Akt\u2013Foxo3a\u2013Caspase-8 signaling pathway","volume":"55","author":"Razzaghi","year":"2023","journal-title":"Amino Acids"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2513837","DOI":"10.1155\/2022\/2513837","article-title":"Ketone body \u03b2-hydroxybutyrate prevents myocardial oxidative stress in septic cardiomyopathy","volume":"2022","author":"Ji","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"178539","DOI":"10.1016\/j.ejphar.2026.178539","article-title":"1, 3-Butanediol Enhances Autophagy via PI3K\/Akt\/FOXO3 Pathway to Ameliorate Cardiac Remodeling Post-Myocardial Infarction","volume":"105","author":"Zhang","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijmm.2016.2563","article-title":"Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K\/Akt\/FoxO3a pathway","volume":"37","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1111\/jcmm.14656","article-title":"GSK-3\u03b2 inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1038\/cddis.2012.5","article-title":"JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure","volume":"3","author":"Chaanine","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00018-023-04755-2","article-title":"The forkhead box O3 (FOXO3): A key player in the regulation of ischemia and reperfusion injury","volume":"80","author":"Omorou","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"glag063","DOI":"10.1093\/gerona\/glag063","article-title":"Protective effects of the FOXO3 gene in cardiometabolic disease in the Concord Health and Ageing in Men Project cohort","volume":"81","author":"Allsopp","year":"2026","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"H1540","DOI":"10.1152\/ajpheart.00549.2016","article-title":"FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress","volume":"311","author":"Chaanine","year":"2016","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e005131","DOI":"10.1161\/CIRCHEARTFAILURE.118.005131","article-title":"Mitochondrial morphology, dynamics, and function in human pressure overload or ischemic heart disease with preserved or reduced ejection fraction","volume":"12","author":"Chaanine","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","article-title":"Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling","volume":"114","author":"Ni","year":"2006","journal-title":"Circulation"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Chang, Y., Li, L., and Yue, H. (2026). SIRT1 in Cardiac Diseases: Molecular Mechanisms, Therapeutic Potential, and Future Directions. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27104216"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Parodi-Rull\u00e1n, R.M., Chapa-Dubocq, X.R., and Javadov, S. (2018). Acetylation of mitochondrial proteins in the heart: The role of SIRT3. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.01094"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/eurjhf\/hfr080","article-title":"AKT signalling in the failing heart","volume":"13","author":"Chaanine","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","article-title":"Is AMPK the savior of the failing heart?","volume":"26","author":"Kim","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_111","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"20814","DOI":"10.1074\/jbc.M500528200","article-title":"The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling","volume":"280","author":"Skurk","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e48876","DOI":"10.7554\/eLife.48876","article-title":"Modulating FOXO3 transcriptional activity by small, DBD-binding molecules","volume":"8","author":"Hagenbuchner","year":"2019","journal-title":"Elife"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41388-019-1044-7","article-title":"A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma","volume":"39","author":"Salcher","year":"2020","journal-title":"Oncogene"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-022-02483-2","article-title":"Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1021\/acs.jmedchem.2c00691","article-title":"Targeting undruggable transcription factors with PROTACs: Advances and perspectives","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"121877","DOI":"10.1016\/j.lfs.2023.121877","article-title":"The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts","volume":"328","author":"Cao","year":"2023","journal-title":"Life Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibs.2014.02.003","article-title":"FOXO transcription factors: Key regulators of cellular quality control","volume":"39","author":"Webb","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10555-020-09883-w","article-title":"FOXO transcription factor family in cancer and metastasis","volume":"39","author":"Jiramongkol","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Xu, M., Zhang, K., and Song, J. (2021). Targeted therapy in cardiovascular disease: A precision therapy era. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.623674"},{"key":"ref_121","first-page":"ehag432","article-title":"Cardiac-targeted delivery of advanced medical therapies for heart disease","volume":"32","author":"Liu","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Dankar, R., Wehbi, J., and Refaat, M.M. (2024). Tailoring treatment in cardiovascular diseases: The role of targeted therapies. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16040461"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Li, D., Son, Y., Jang, M., Wang, S., and Zhu, W. (2023). Nanoparticle based cardiac specific drug delivery. Biology, 12.","DOI":"10.3390\/biology12010082"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/1061186X.2020.1818761","article-title":"Therapeutic advances in cardiac targeted drug delivery: From theory to practice","volume":"29","author":"Li","year":"2021","journal-title":"J. Drug Target."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"23509","DOI":"10.18632\/aging.202175","article-title":"FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1161\/JAHA.113.000016","article-title":"Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy","volume":"2","author":"Cao","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"C38","DOI":"10.1152\/ajpcell.00315.2009","article-title":"FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70","volume":"298","author":"Senf","year":"2010","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"ehaa946.3643","DOI":"10.1093\/ehjci\/ehaa946.3643","article-title":"Novel effects of Foxo3a on immune system and cardiac remodeling after myocardial infarction","volume":"41","author":"Karadeniz","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","article-title":"FOXO transcription factors as therapeutic targets in human diseases","volume":"43","author":"Paik","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_130","first-page":"677","article-title":"Derisking Phase II Clinical Trials in Heart Failure: A Position Paper from JACC: Basic to Translational Science and the Heart Failure Collaboratory","volume":"10","author":"Mann","year":"2025","journal-title":"Basic Transl. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2015.03.043","article-title":"Patient selection in heart failure with preserved ejection fraction clinical trials","volume":"65","author":"Kelly","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1002\/ctm2.1258","article-title":"Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy","volume":"13","author":"Cheng","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1152\/ajpendo.00062.2020","article-title":"Circulating extracellular vesicles from patients with valvular heart disease induce neutrophil chemotaxis via FOXO3a and the inhibiting role of dexmedetomidine","volume":"319","author":"Yuan","year":"2020","journal-title":"Am. J. Physiol.-Endocrinol. Metab."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1460\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:31:51Z","timestamp":1789461111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":134,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091460"],"URL":"https:\/\/doi.org\/10.3390\/ph19091460","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}